Yang-Xin Fu

52PUBLICATIONS
173CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyElectrical circuits and systemsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Sep 10, 2026
αTIGIT-guided IL-15 mimetics drive potent and safe antitumor immunity by restoring tumor-infiltrating T cells.

|Jul 23, 2026
Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy.

|Jun 02, 2026
Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity.

|Apr 22, 2026
Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity.

|Apr 16, 2026
Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistance.

|Mar 18, 2026
Reactivating exhausted tumor-infiltrating T cells by a bispecific DC-T cell engager in mice.

Xuhao Zhang, Yu Gao, Wenbo Hu

Pageof 9

Frequent Collaborators

11 joint publications

Hua Peng

6 joint publications

Wenyan Wang

5 joint publications

Zhichen Sun

3 joint publications

Huiyu Li